Related references
Note: Only part of the references are listed.Clinical validation of Guardant360 CDx as a blood-based companion diagnostic for sotorasib
Joshua M. Bauml et al.
LUNG CANCER (2022)
Cell free circulating tumor DNA in cerebrospinal fluid detects and monitors central nervous system involvement of B-cell lymphomas
Sabela Bobillo et al.
HAEMATOLOGICA (2021)
Profiling of Circulating Tumor DNA for Noninvasive Disease Detection, Risk Stratification, and MRD Monitoring in Patients with CNS Lymphoma
Jurik Andreas Mutter et al.
BLOOD (2021)
Serial assessment of measurable residual disease in medulloblastoma liquid biopsies
Anthony P. Y. Liu et al.
CANCER CELL (2021)
Molecular diagnosis of diffuse glioma using a chip-based digital PCR system to analyze IDH, TERT, and H3 mutations in the cerebrospinal fluid
Yutaka Fujioka et al.
JOURNAL OF NEURO-ONCOLOGY (2021)
Urinary Molecular Pathology for Patients with Newly Diagnosed Urothelial Bladder Cancer
Ruiyun Zhang et al.
JOURNAL OF UROLOGY (2021)
Standardization of the liquid biopsy for pediatric diffuse midline glioma using ddPCR
Daphne Li et al.
SCIENTIFIC REPORTS (2021)
Cell-free DNA from cerebrospinal fluid can be used to detect the EGFR mutation status of lung adenocarcinoma patients with central nervous system metastasis
Yang Liu et al.
TRANSLATIONAL LUNG CANCER RESEARCH (2021)
Detection of tumor-derived cell-free DNA from colorectal cancer peritoneal metastases in plasma and peritoneal fluid
Iris Van't Erve et al.
JOURNAL OF PATHOLOGY CLINICAL RESEARCH (2021)
Cell-free DNA from bile outperformed plasma as a potential alternative to tissue biopsy in biliary tract cancer
Q. Gou et al.
ESMO OPEN (2021)
Liquid Biopsy from Bile-Circulating Tumor DNA in Patients with Biliary Tract Cancer
Jin-Yi Han et al.
CANCERS (2021)
Analysis of the Gut Microbiota: An Emerging Source of Biomarkers for Immune Checkpoint Blockade Therapy in Non-Small Cell Lung Cancer
Feiyu Zhang et al.
CANCERS (2021)
Signed in Blood: Circulating Tumor DNA in Cancer Diagnosis, Treatment and Screening
Jacob J. Adashek et al.
CANCERS (2021)
Clinical Utility of Cell-free and Circulating Tumor DNA in Kidney and Bladder Cancer: A Critical Review of Current Literature
Elizabeth A. Green et al.
EUROPEAN UROLOGY ONCOLOGY (2021)
Circulating tumor cell free DNA from plasma and urine in the clinical management of colorectal cancer
Haiying Yu et al.
CANCER BIOMARKERS (2020)
Evaluating liquid biopsies for methylomic profiling of prostate cancer
Romina Silva et al.
EPIGENETICS (2020)
Clinical Implications of Circulating Tumor DNA from Ascites and Serial Plasma in Ovarian Cancer
Mi-Ryung Han et al.
CANCER RESEARCH AND TREATMENT (2020)
Comprehensive characterization of cell-free tumor DNA in plasma and urine of patients with renal tumors
Christopher G. Smith et al.
GENOME MEDICINE (2020)
The art of obtaining a high yield of cell-free DNA from urine
Elien Augustus et al.
PLOS ONE (2020)
Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA
M. C. Liu et al.
ANNALS OF ONCOLOGY (2020)
Peritoneal Cell-Free Tumor DNA as Biomarker for Peritoneal Surface Malignancies
Katie M. Leick et al.
ANNALS OF SURGICAL ONCOLOGY (2020)
Ultra-Short Circulating Tumor DNA (usctDNA) in Plasma and Saliva of Non-Small Cell Lung Cancer (NSCLC) Patients
Feng Li et al.
CANCERS (2020)
Probing of breast cancer using a combination of plasma and urinary circulating cell-free DNA
Zhigang Zuo et al.
BIOSCIENCE REPORTS (2020)
Detection of renal cell carcinoma using plasma and urine cell-free DNA methylomes
Pier Vitale Nuzzo et al.
NATURE MEDICINE (2020)
Clinical and analytical validation of FoundationOne Liquid CDx, a novel 324-Gene cfDNA-based comprehensive genomic profiling assay for cancers of solid tumor origin
Ryan Woodhouse et al.
PLOS ONE (2020)
Prostate cancer evolution from multilineage primary to single lineage metastases with implications for liquid biopsy
D. J. Woodcock et al.
NATURE COMMUNICATIONS (2020)
COVID-19 and Oncology: Service transformation during pandemic
Marco Shiu Tsun Leung et al.
CANCER MEDICINE (2020)
Reliable tumor detection by whole-genome methylation sequencing of cell-free DNA in cerebrospinal fluid of pediatric medulloblastoma
Jia Li et al.
SCIENCE ADVANCES (2020)
Liquid Biopsy of Non-Plasma Body Fluids in Non-Small Cell Lung Cancer: Look Closer to the Tumor!
Lucile Durin et al.
CELLS (2020)
Genetic profiling of cerebrospinal fluid cfDNA from NSCLC patients with leptomeningeal metastases reveals EGFR-TKIs resistant mutations independent of extracranial lesions (cases series)
Xi Wu et al.
CANCER RESEARCH (2020)
Circulating tumour DNA from the cerebrospinal fluid allows the characterisation and monitoring of medulloblastoma
Laura Escudero et al.
NATURE COMMUNICATIONS (2020)
Liquid biopsy in peritoneal fluid and plasma as a prognostic factor in advanced colorectal and appendiceal tumors after complete cytoreduction and hyperthermic intraperitoneal chemotherapy
Irene Lopez-Rojo et al.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2020)
ctDNA as a cancer biomarker: A broad overview
Luciana Santos Pessoa et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2020)
Detection of bladder cancer using urinary cell-free DNA and cellular DNA
Zhenyu Ou et al.
CLINICAL AND TRANSLATIONAL MEDICINE (2020)
Clinical Utility of Cerebrospinal Fluid Cell-Free DNA as Liquid Biopsy for Leptomeningeal Metastases in ALK-Rearranged NSCLC
Mei-Mei Zheng et al.
JOURNAL OF THORACIC ONCOLOGY (2019)
Tracking tumour evolution in glioma through liquid biopsies of cerebrospinal fluid
Alexandra M. Miller et al.
NATURE (2019)
Tumor cell-free DNA detection in CSF for primary CNS lymphoma diagnosis
V. Rimelen et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2019)
Clinical validity of saliva and novel technology for cancer detection
Karolina Elzbieta Kaczor-Urbanowicz et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2019)
Early Detection of Metastatic Relapse and Monitoring of Therapeutic Efficacy by Ultra-Deep Sequencing of Plasma Cell-Free DNA in Patients With Urothelial Bladder Carcinoma
Emil Christensen et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Analysis of mutation detection in cell-free DNA in ascites using comprehensive NGS panel.
Chunmei Shi et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Genome-wide cell-free DNA fragmentation in patients with cancer
Stephen Cristiano et al.
NATURE (2019)
Potential use of transrenal DNA for non-invasive monitoring and prognosis of colorectal cancer
Wei Chen et al.
BIOMARKERS (2019)
Comparison of circulating tumor DNA between body fluids in patients with primary central nervous system lymphoma
Jun Watanabe et al.
LEUKEMIA & LYMPHOMA (2019)
Malignant Pleural Effusion and Its Current Management: A Review
Kristijan Skok et al.
MEDICINA-LITHUANIA (2019)
Salivary HPV DNA informs locoregional disease status in advanced HPV-associated oropharyngeal cancer
Glenn J. Hanna et al.
ORAL ONCOLOGY (2019)
Cost-effectiveness of a multitarget stool DNA test for colorectal cancer screening of Medicare beneficiaries
Steffie K. Naber et al.
PLOS ONE (2019)
Saliva-derived cfDNA is applicable for EGFR mutation detection but not for quantitation analysis in non-small cell lung cancer
Shanshan Ding et al.
THORACIC CANCER (2019)
How liquid biopsies can change clinical practice in oncology
G. Siravegna et al.
ANNALS OF ONCOLOGY (2019)
Quick assessment of cell-free DNA in seminal fluid and fragment size for early non-invasive prostate cancer diagnosis
Giovanni Ponti et al.
CLINICA CHIMICA ACTA (2019)
Cerebrospinal fluid cell-free tumour DNA as a liquid biopsy for primary brain tumours and central nervous system metastases
J. Seoane et al.
ANNALS OF ONCOLOGY (2019)
Phase 1b trial of an ibrutinib-based combination therapy in recurrent/refractory CNS lymphoma
Christian Grommes et al.
BLOOD (2019)
Unique genomic profiles obtained from cerebrospinal fluid cell-free DNA of non-small cell lung cancer patients with leptomeningeal metastases
Shenpeng Ying et al.
CANCER BIOLOGY & THERAPY (2019)
Evaluating the cerebrospinal fluid ctDNA detection by next-generation sequencing in the diagnosis of meningeal Carcinomatosis
Yue Zhao et al.
BMC NEUROLOGY (2019)
Current and future perspectives of liquid biopsies in genomics-driven oncology
Ellen Heitzer et al.
NATURE REVIEWS GENETICS (2019)
Detection and Surveillance of Bladder Cancer Using Urine Tumor DNA
Jonathan C. Dudley et al.
CANCER DISCOVERY (2019)
Clinical Implications of Plasma-Based Genotyping With the Delivery of Personalized Therapy in Metastatic Non-Small Cell Lung Cancer
Charu Aggarwal et al.
JAMA ONCOLOGY (2019)
Whole exome sequencing analysis of urine trans-renal tumour DNA in metastatic colorectal cancer patients
Giovanni Crisafulli et al.
ESMO OPEN (2019)
Tumor-derived DNA from pleural effusion supernatant as a promising alternative to tumor tissue in genomic profiling of advanced lung cancer
Lin Tong et al.
THERANOSTICS (2019)
High Detection Rate of MYD88 Mutations in Cerebrospinal Fluid From Patients With CNS Lymphomas
Jun Watanabe et al.
JCO PRECISION ONCOLOGY (2019)
Concordance of Circulating Tumor DNA and Matched Metastatic Tissue Biopsy in Prostate Cancer
Alexander W. Wyatt et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2018)
Concordance of Circulating Tumor DNA and Matched Metastatic Tissue Biopsy in Prostate Cancer
Alexander W. Wyatt et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2018)
Unique genetic profiles from cerebrospinal fluid cell-free DNA in leptomeningeal metastases of EGFR-mutant non-small-cell lung cancer: a new medium of liquid biopsy
Y. S. Li et al.
ANNALS OF ONCOLOGY (2018)
The Landscape of Actionable Genomic Alterations in Cell-Free Circulating Tumor DNA from 21,807 Advanced Cancer Patients
Oliver A. Zill et al.
CLINICAL CANCER RESEARCH (2018)
Molecular Diagnosis of Diffuse Gliomas through Sequencing of Cell-Free Circulating Tumor DNA from Cerebrospinal Fluid
Francisco Martinez-Ricarte et al.
CLINICAL CANCER RESEARCH (2018)
Circulating Tumor DNA Analysis in Patients With Cancer: American Society of Clinical Oncology and College of American Pathologists Joint Review
Jason D. Merker et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Early stage NSCLC - challenges to implementing ctDNA-based screening and MRD detection
Christopher Abbosh et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
WHO 2016 Classification of gliomas
P. Wesseling et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2018)
Seminal Cell-Free DNA Assessment as a Novel Prostate Cancer Biomarker
Giovanni Ponti et al.
PATHOLOGY & ONCOLOGY RESEARCH (2018)
Detection and localization of surgically resectable cancers with a multi-analyte blood test
Joshua D. Cohen et al.
SCIENCE (2018)
Urinary cell-free nucleic acid IQGAP3: a new non-invasive diagnostic marker for bladder cancer
Won Tae Kim et al.
Oncotarget (2018)
Non-invasive detection of urothelial cancer through the analysis of driver gene mutations and aneuploidy
Simeon U. Springer et al.
ELIFE (2018)
Prevalence of Clonal Hematopoiesis Mutations in Tumor-Only Clinical Genomic Profiling of Solid Tumors
Ryan N. Ptashkin et al.
JAMA ONCOLOGY (2018)
Next-generation sequencing unravels extensive genetic alteration in recurrent ovarian cancer and unique genetic changes in drug-resistant recurrent ovarian cancer
Zhen-Hua Du et al.
MOLECULAR GENETICS & GENOMIC MEDICINE (2018)
EFIRM liquid biopsy (eLB): Detection of ultra-short circulating tumor DNA (usctDNA) in plasma and saliva of non-small cell lung cancer (NSCLC) patients.
Feng Li et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
P05.09 Detection of clinically relevant mutations in the cerebrospinal fluid of patients with central nervous system metastases
I Moya et al.
NEURO-ONCOLOGY (2018)
The impact of sample type and procedural attributes on relative acceptability of different colorectal cancer screening regimens
Joanne M. Osborne et al.
PATIENT PREFERENCE AND ADHERENCE (2018)
Clinically Relevant and Minimally Invasive Tumor Surveillance of Pediatric Diffuse Midline Gliomas Using Patient-Derived Liquid Biopsy
Eshini Panditharatna et al.
CLINICAL CANCER RESEARCH (2018)
Detection of cell-free DNA fragmentation and copy number alterations in cerebrospinal fluid from glioma patients
Florent Mouliere et al.
EMBO MOLECULAR MEDICINE (2018)
Urinary cell-free DNA as a prognostic marker for KRAS-positive advanced-stage NSCLC
F. Xie et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2018)
Saliva diagnostics - Current views and directions
Karolina Elzbieta Kaczor-Urbanowicz et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2017)
Salivary biomarkers in cancer detection
Xiaoqian Wang et al.
MEDICAL ONCOLOGY (2017)
Liquid Biopsy Analysis of FGFR3 and PIK3CA Hotspot Mutations for Disease Surveillance in Bladder Cancer
Emil Christensen et al.
EUROPEAN UROLOGY (2017)
Unique Genetic Profiles from Circulating Cell-Free DNA of Cerebrospinal Fluid in Leptomeningeal Metastases of EGFR Mutant NSCLC
B. Jiang et al.
JOURNAL OF THORACIC ONCOLOGY (2017)
EGFR Mutation Status Analysis in Cerebrospinal Fluid and Plasma of Advanced Lung Adenocarcinoma with Brain Metastases
Liang Shi et al.
JOURNAL OF THORACIC ONCOLOGY (2017)
Gene mutations in stool from gastric and colorectal neoplasia patients by next-generation sequencing
Omar Youssef et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2017)
Multitarget stool DNA tests increases colorectal cancer screening among previously noncompliant Medicare patients
Mark Prince et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2017)
Lung cancer genomic alterations in cell free DNA in pleural effusion compared to plasma.
Zhenzhen Zhou et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Variations in transrenal DNA and comparison with plasma DNA as a diagnostic marker for colorectal cancer
Fang Tian et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS (2017)
Molecular stool testing as an alternative for surveillance colonoscopy: a cross-sectional cohort study
Meta C. J. van Lanschot et al.
BMC CANCER (2017)
Origins, structures, and functions of circulating DNA in oncology
A. R. Thierry et al.
CANCER AND METASTASIS REVIEWS (2016)
Comparative analysis of circulating tumor DNA stability In K3EDTA, Streck, and CellSave blood collection tubes
Qing Kang et al.
CLINICAL BIOCHEMISTRY (2016)
Genomic complexity of urothelial bladder cancer revealed in urinary cfDNA
Fiona S. Togneri et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2016)
Genomic Alterations in Liquid Biopsies from Patients with Bladder Cancer
Karin Birkenkamp-Demtroder et al.
EUROPEAN UROLOGY (2016)
Evaluation and comparison of in vitro degradation kinetics of DNA in serum, urine and saliva: A qualitative study
Wang Yao et al.
GENE (2016)
Evaluating Cancer of the Central Nervous System Through Next-Generation Sequencing of Cerebrospinal Fluid
Elena I. Pentsova et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Association Between Plasma Genotyping and Outcomes of Treatment With Osimertinib (AZD9291) in Advanced Non-Small-Cell Lung Cancer
Geoffrey R. Oxnard et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Tumor DNA in cerebral spinal fluid reflects clinical course in a patient with melanoma leptomeningeal brain metastases
Yingmei Li et al.
JOURNAL OF NEURO-ONCOLOGY (2016)
A Highly Sensitive and Quantitative Test Platform for Detection of NSCLC EGFR Mutations in Urine and Plasma
Karen L. Reckamp et al.
JOURNAL OF THORACIC ONCOLOGY (2016)
Monitoring KRAS mutations in circulating DNA and tumor cells using digital droplet PCR during treatment of KRAS-mutated lung adenocarcinoma
Nicolas Guibert et al.
LUNG CANCER (2016)
Stool DNA Testing for Screening Detection of Colorectal Neoplasia in Alaska Native People
Diana G. Redwood et al.
MAYO CLINIC PROCEEDINGS (2016)
New trends in molecular and cellular biomarker discovery for colorectal cancer
Parisa Aghagolzadeh et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2016)
Evaluation of a novel saliva-based epidermal growth factor receptor mutation detection for lung cancer: A pilot study
Dan Pu et al.
THORACIC CANCER (2016)
Fragment Length of Circulating Tumor DNA
Hunter R. Underhill et al.
PLOS GENETICS (2016)
Genomic Analysis of Uterine Lavage Fluid Detects Early Endometrial Cancers and Reveals a Prevalent Landscape of Driver Mutations in Women without Histopathologic Evidence of Cancer: A Prospective Cross-Sectional Study
Navya Nair et al.
PLOS MEDICINE (2016)
Non-invasive urine testing of EGFR activating mutation and T790M resistance mutation in non-small cell lung cancer
David Berz et al.
EXPERIMENTAL HEMATOLOGY & ONCOLOGY (2016)
Analysis of cell-free tumor DNA in cerebrospinal fluid to characterize and monitor the genetic alterations of brain tumors
Leticia De Mattos-Arruda et al.
CANCER RESEARCH (2015)
Brain Tumor Mutations Detected in Cerebral Spinal Fluid
Wenying Pan et al.
CLINICAL CHEMISTRY (2015)
Urine Cell-Free DNA Integrity Analysis for Early Detection of Prostate Cancer Patients
Samanta Salvi et al.
DISEASE MARKERS (2015)
Detection of endometrial cancer via molecular analysis of DNA collected with vaginal tampons
Jamie N. Bakkum-Gamez et al.
GYNECOLOGIC ONCOLOGY (2015)
The high prevalence of undiagnosed prostate cancer at autopsy: implications for epidemiology and treatment of prostate cancer in the Prostate-specific Antigen-era
Jaquelyn L. Jahn et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Detection of somatic mutations and HPV in the saliva and plasma of patients with head and neck squamous cell carcinomas
Yuxuan Wang et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Review of the Different Treatments and Management for Prostate Cancer and Fertility
Stephanie Tran et al.
UROLOGY (2015)
Cerebrospinal fluid-derived circulating tumour DNA better represents the genomic alterations of brain tumours than plasma
Leticia De Mattos-Arruda et al.
NATURE COMMUNICATIONS (2015)
Addressing health disparities in Hispanic breast cancer: accurate and inexpensive sequencing of BRCA1 and BRCA2
Michael Dean et al.
GIGASCIENCE (2015)
Frameless image-guided stereotactic brain biopsies: emphasis on diagnostic yield
Sodaba Khatab et al.
ACTA NEUROCHIRURGICA (2014)
Noninvasive Saliva-based EGFR Gene Mutation Detection in Patients with Lung Cancer
Fang Wei et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2014)
Capturing intra-tumor genetic heterogeneity by de novo mutation profiling of circulating cell-free tumor DNA: a proof-of-principle
L. De Mattos-Arruda et al.
ANNALS OF ONCOLOGY (2014)
Noninvasive Detection of Response and Resistance in EGFR-Mutant Lung Cancer Using Quantitative Next-Generation Genotyping of Cell-Free Plasma DNA
Geoffrey R. Oxnard et al.
CLINICAL CANCER RESEARCH (2014)
Sensitive Detection of EGFR Mutations in Cerebrospinal Fluid from Lung Adenocarcinoma Patients with Brain Metastases
Haihong Yang et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2014)
Multitarget Stool DNA Testing for Colorectal-Cancer Screening
Thomas F. Imperiale et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
Chetan Bettegowda et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Saliva and Plasma Quantitative Polymerase Chain Reaction-Based Detection and Surveillance of Human Papillomavirus-Related Head and Neck Cancer
Sun M. Ahn et al.
JAMA OTOLARYNGOLOGY-HEAD & NECK SURGERY (2014)
Urine Cell-Free DNA Integrity as a Marker for Early Prostate Cancer Diagnosis: A Pilot Study
Valentina Casadio et al.
BIOMED RESEARCH INTERNATIONAL (2013)
BEAMing and Droplet Digital PCR Analysis of Mutant IDH1 mRNA in Glioma Patient Serum and Cerebrospinal Fluid Extracellular Vesicles
Walter W. Chen et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2013)
Pleural fluid cell-free DNA integrity index to identify cytologically negative malignant pleural effusions including mesotheliomas
Krishna B. Sriram et al.
BMC CANCER (2012)
Stool DNA testing for the detection of pancreatic cancer Assessment of Methylation Marker Candidates
John B. Kisiel et al.
CANCER (2012)
Detection of Tumor PIK3CA Status in Metastatic Breast Cancer Using Peripheral Blood
Michaela J. Higgins et al.
CLINICAL CANCER RESEARCH (2012)
High Fragmentation Characterizes Tumour-Derived Circulating DNA
Florent Mouliere et al.
PLOS ONE (2011)
Cell-free nucleic acids as biomarkers in cancer patients
Heidi Schwarzenbach et al.
NATURE REVIEWS CANCER (2011)
Maternal Plasma DNA Sequencing Reveals the Genome-Wide Genetic and Mutational Profile of the Fetus
Y. M. Dennis Lo et al.
SCIENCE TRANSLATIONAL MEDICINE (2010)
Quick recovery and characterization of cell-free DNA in seminal plasma of normozoospermia and azoospermia: implications for non-invasive genetic utilities
Hong-Gang Li et al.
ASIAN JOURNAL OF ANDROLOGY (2009)
Noninvasive Molecular Detection of Head and Neck Squamous Cell Carcinoma An Exploratory Analysis
Seema Sethi et al.
DIAGNOSTIC MOLECULAR PATHOLOGY (2009)
Transrenal nucleic acids: From proof of principle to clinical tests - Problems and solutions
Hovsep S. Melkonyan et al.
CIRCULATING NUCLEIC ACIDS IN PLASMA AND SERUM V (2008)
Circulating mutant DNA to assess tumor dynamics
Frank Diehl et al.
NATURE MEDICINE (2008)
Urinary cell-free DNA as a potential tumor marker for bladder cancer
H. W. Chang et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS (2007)
Free DNA in urine: A new marker for bladder cancer? Preliminary data
M Zancan et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS (2005)
Fecal DNA versus fecal occult blood for colorectal-cancer screening in an average-risk population
TF Imperiale et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Human urine contains small, 150 to 250 nucleotide-sized, soluble DNA derived from the circulation and may be useful in the detection of colorectal cancer
YH Su et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2004)
Quantification of human DNA in feces as a diagnostic test for the presence of colorectal cancer.
CHW Klaassen et al.
CLINICAL CHEMISTRY (2003)
Share Paper
